Faster global financial news!
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50% greater pain relief than hydrocodone in a 343-patient trial, positioning it for a potential opioid-free label claim. Phase 3 trials for LTG-001 are set to launch in the second half of 2026, with results expected in the second half of 2027.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Yangtze Optical Fibre and Cable (YOFC) plunged 16.03% in Hong Kong trading, while UBS bucked the trend by raising its net profit forecasts for the company by 116%-158% for 2026-28 and maintaining a "buy" rating.
-
2
Renowned investor Duan Yongping has once again purchased 30,000 shares of Kweichow Moutai, spending over 36.9 million yuan.
-
3
NEAR Protocol (NEAR) Outlook: Future Potential Driven by Technological Innovation and Ecosystem Expansion
-
4
XRP's Global Acceptance and Impact: Regulation, Applications, and Market Dynamics
-
5
THC Coin Analysis: Trading Status and Risks of Transhuman Coin and Thetan Coin
-
6
SAITAMA Coin: An Analysis of Its Evolution from Meme to SaitaChain and Current Status
-
7
DEXA Coin: An Analysis of the Current Status of the ERC-20 Token Formerly Positioned for Social Payments
-
8
Zhuhai Amicro Technology, a robot chip designer backed by Xiaomi, has passed its listing hearing and plans to raise over $100 million in an IPO in Hong Kong.
-
9
Cryptocurrency Exchange Selection Guide: Global Compliance and Risk Analysis
-
10
GOETH Token Analysis: Wrapped Ethereum on Algorand and Its Market Dynamics
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
